A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma. — المؤلف: D'Angelo, Sandra P — Investigational new drugs 20181227
- المؤلف
- D'Angelo, Sandra P
- النشر
- Investigational new drugs 20181227
- الوصف
- 103-113 p.
- الموضوعات
- Adult؛ Aged؛ Aged, 80 and over؛ Antibodies, Monoclonal, Humanized؛ Antigens, CD؛ Antigens, Neoplasm؛ Antineoplastic Agents؛ Female